Trial Profile
Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase 0
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Molluscum contagiosum
- Focus Therapeutic Use
- 21 Mar 2022 Status changed from recruiting to withdrawn prior to enrolment.
- 24 Jan 2018 Status changed from not yet recruiting to recruiting.
- 15 Nov 2017 New trial record